Be a Smart Investor
Monday, January 9, 2017
Japan's Takeda to buy US cancer drug maker Ariad in $5.2 billion deal
Japan's Takeda Pharmaceutical said on Monday it would acquire cancer drugmaker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion.
from Mergers and Acquisitions http://ift.tt/2jkVbPW
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment